GORDON SCHUTZE to Risk Assessment
This is a "connection" page, showing publications GORDON SCHUTZE has written about Risk Assessment.
Connection Strength
0.047
-
Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections. Pediatr Infect Dis J. 2004 Feb; 23(2):110-4.
Score: 0.024
-
The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2016 11; 138(5).
Score: 0.015
-
Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007 Feb; 150(2):180-4, 184.e1.
Score: 0.008